Refresh

Bal Pharma Ltd - Board Meeting Outcome for Outcome Of The Board Meeting_12.11.2025


Download
12 Nov 2025
Board of Directors of the Company has inter alia 1. Approved the unaudited standalone and consolidate financial results for the quarter ended 30.09.2025. 2. Appointed Dr.B.Mukesh ( DIN # 11295580)as additional Director of the Company.

Source: BSE India

View all announcements for Bal Pharma Ltd
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com